Erlotinib-d6 hydrochloride

SL-9439

Erlotinib-d₆ hydrochloride, >98%

CAS No. : [1189953-78-3]

Synonyms : NSC 718781-d₆; OSI-744-d₆; R1415-d₆

IUPAC Name : N-(3-Ethynylphenyl)-6,7-bis(2-(methoxy-d₃)ethoxy)quinazolin-4-amine hydrochloride

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
10MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
25MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
50MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026

Applications : This is a deuterium labelled version of Erlotinib, which is a potent, selective inhibitor of EGFR. Erlotinib is a targeted therapeutic agent indicated for the treatment of specific malignancies, most notably non-small cell lung cancer (NSCLC) and pancreatic cancer.

References : Ng S. S. et al.: Mol Cancer Ther., 1(10), 777-783, 2002; Moyer J. D. et al. Cancer Res., 57(21), 4838-48, 1997; Pollack V. A. et al.: J. Pharmacol Exp Ther., 291(2), 739-748, 1999.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.